21.23%) across the entire cohort, this difference did not reach statistical significance.
← all excerpts
The effects of daratumumab on bone disease in patients with newly diagnosed multiple myeloma: a multi-center retrospective study.
1
—
—
21.23%) across the entire cohort, this difference did not reach statistical significance.